We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » PROBE PBM-DRUGMAKER DEALS AND INCENTIVES, SENATORS SAY
PROBE PBM-DRUGMAKER DEALS AND INCENTIVES, SENATORS SAY
October 5, 2004
Concerned about conflicts of interest in the business practices of pharmaceutical benefit managers (PBMs), a bipartisan group of senators wants the FTC to expand a study by examining deals with drugmakers and the extent to which PBMs pass on financial incentives through the distribution channel.